The Business APAC Healthcare Elites of 2019​ Final File_Healthcare Elites | Page 19

Presently, Alniche has partnered with Global Pharma
Organizations to bring novel Global Brands in India from
various organizations including J.W. Lifesciences (Korea),
Adhezion Biomedical Inc. (USA), FzioMed (USA),
Advancis Medical (UK), PT Dermozone Pratama
(Indonesia), Biovite (Australia), and Mastix (USA). In
addition, Alniche is also working with various global
companies that focus on therapy differentiation and ground-
breaking product concepts. attitude of taking business risks has also contributed to the
firm’s success. He owes a lot to his mentors who sharpened
his skills and helped him to get the feat right. He
acknowledges the efforts of Ms. Ritu Hasija, (Director
Corporate Affairs) for her incessant support right since the
inception of the company.
Recently, Alniche has formed an R&D alliance with Delhi
Pharmaceutical Sciences & Research University (DPSRU);
India’s first Pharmacy University. This affiliation of
industry and academia promises to augment further
development of new products enabling innovations, growth
in the education system, and employment. It also ensures to
meet the medical needs of Indian population. Additionally,
Alniche has instituted awards to encourage the young
researchers for the new research and innovative products &
ideas. Over the years, India is tagged as the ‘pharmacy of the
world’ as it is the largest provider of generic drugs globally.
It supplies over 50 percent of global demand for various
vaccines, 40 percent of generic demand in the US, and 25
percent of all medicines in UK. This is not all. Companies
around the world are actively applauding the Indian CRO &
CMO for their excellent deliverables and efficiency. But
there are certain challenges faced by the pharma companies
like compliance issues and good manufacturing practices.
Challenges and Opportunities in Life Sciences Sector in
India
One more major challenge is the disjointed structure of the
industry as there are abundant generic manufacturers
leading to instability, volatility, and uncertainty. Sometimes,
the competition between big, mid-sized, and small players
can also lead to low quality compliance. To top it all, the
competitive pressure and government pricing policies adds
to the low margin profits. Even the inputs for research and
development are very low which affects the R&D
departments of the companies and the development of new
products. The stronger IP regulation has also been a big
issue for companies. But positively, the Indian government
has taken many steps to manage medicine costs and overall
affordability of healthcare expenditures.
Alniche is achieving these milestones because of its strong
and proficient senior management team. This expert team
comprises of cohesive and endowed professionals, making
it an exceptional combination of talent, skills, knowledge,
and business acumen.
Leader who believes in Togetherness and Growth for All
Mr. Girish Arora, the Founder and Managing Director
of Alniche Lifesciences, established the firm keeping one
thing in mind—‘Attached to the ground and aiming the
sky’. He has earned experience of more than 30 years in
Indian and global pharma market. His expertise and vision
has directed the organization into prominent therapy areas
that helped to reach an exceptional position. He has always
believed in hard work, team efforts, honesty, togetherness,
and God’s grace. His ability of decision-making and
We at Alniche Lifesciences are envisioned
to bring novel products across various therapies
and establish deep engagement with the medical
fraternity.
businessapac.com
19
March 2019